Literature DB >> 12604332

Comparative effects of basophil-directed growth factors.

Chitose Yoshimura-Uchiyama1, Masao Yamaguchi, Hiroyuki Nagase, Takao Fujisawa, Chisei Ra, Kouji Matsushima, Tsutomu Iwata, Takashi Igarashi, Kazuhiko Yamamoto, Koichi Hirai.   

Abstract

IL-3, IL-5, and GM-CSF exert various overlapping functions in basophils. We investigated the receptor expression profiles and concentration-dependent effects of IL-3, IL-5, and GM-CSF on several basophil functions in comparison with their effects on eosinophils. The order of the receptor expression levels was IL-3Ralpha>IL-5Ralpha>GM-CSFRalpha in basophils and IL-5Ralpha>or=GM-CSFRalpha>IL-3Ralpha in eosinophils. Compared with eosinophils, basophils expressed a much higher level of IL-3Ralpha and similar levels of IL-5Ralpha and GM-CSFRalpha. The order of potency was IL-3>IL-5=GM-CSF for degranulation, survival, and CD11b expression in basophils, and IL-5=GM-CSF>or=IL-3 for survival and CD11b expression in eosinophils. However, IL-3 induced CD69 expression preferentially in basophils. Our results indicate that IL-3 is the most potent activator of human basophils, and that the rank order of potency of hemopoietic growth factors virtually corresponded to their receptor expression levels in both cell types.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12604332     DOI: 10.1016/s0006-291x(03)00153-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  Pharmacokinetics and pharmacodynamics of mepolizumab, an anti-interleukin-5 monoclonal antibody.

Authors:  Deborah A Smith; Elisabeth A Minthorn; Misba Beerahee
Journal:  Clin Pharmacokinet       Date:  2011-04       Impact factor: 6.447

Review 2.  Essential Mechanisms of Differential Activation of Eosinophils by IL-3 Compared to GM-CSF and IL-5.

Authors:  Stephane Esnault; Elizabeth A Kelly
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

Review 3.  The Evolution of Human Basophil Biology from Neglect towards Understanding of Their Immune Functions.

Authors:  Markus Steiner; Sara Huber; Andrea Harrer; Martin Himly
Journal:  Biomed Res Int       Date:  2016-12-19       Impact factor: 3.411

4.  New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic.

Authors:  Marco Caminati; Diego Bagnasco; Rachele Vaia; Gianenrico Senna
Journal:  Biologics       Date:  2019-05-22

Review 5.  Basophils Orchestrating Eosinophils' Chemotaxis and Function in Allergic Inflammation.

Authors:  Joseena Iype; Michaela Fux
Journal:  Cells       Date:  2021-04-14       Impact factor: 6.600

6.  Mepolizumab decreased the levels of serum galectin-10 and eosinophil cationic protein in asthma.

Authors:  Konomi Kobayashi; Hiroyuki Nagase; Naoya Sugimoto; Shiho Yamamoto; Akihiko Tanaka; Koichi Fukunaga; Ryo Atsuta; Etsuko Tagaya; Masayuki Hojo; Yasuhiro Gon
Journal:  Asia Pac Allergy       Date:  2021-07-16

7.  Characterization of the relationship between dose and blood eosinophil response following subcutaneous administration of mepolizumab.

Authors:  Isabelle J Pouliquen; Oliver Kornmann; Sharon V Barton; Jeffrey A Price; Hector G Ortega
Journal:  Int J Clin Pharmacol Ther       Date:  2015-12       Impact factor: 1.366

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.